Publication: The next forum for unraveling FDA off-label marketing rules: State and federal legislatures
Loading...
Open/View Files
Date
2018
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Sinha, Michael S., and Aaron S. Kesselheim. 2018. “The next forum for unraveling FDA off-label marketing rules: State and federal legislatures.” PLoS Medicine 15 (5): e1002564. doi:10.1371/journal.pmed.1002564. http://dx.doi.org/10.1371/journal.pmed.1002564.
Abstract
In a Guest Editorial, Aaron S. Kesselheim and Michael S. Sinha show how federal and state legislation to allow promotion of drugs for non-approved uses threatens to undermine the FDA's public health mission.
Description
Other Available Sources
Research Data
Keywords
People and Places, Population Groupings, Professions, Medical Personnel, Medical Doctors, Physicians, Medicine and Health Sciences, Health Care, Health Care Providers, Social Sciences, Sociology, Marketing, Law and Legal Sciences, Legislation, Public and Occupational Health, Linguistics, Speech, Pharmacology, Drug Research and Development, Drug Marketing, Peer Review
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service